- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Important, 08-04-2026: Updates
08-04-2026 | 08:40 am
08-04-2026 | 08:40 am
Biocon Pharma secured US FDA approval for Dapagliflozin Tablets (5mg & 10mg) for Type 2 diabetes. This expands the company's strong diabetes portfolio and global market reach.
No comments yet. Be the first to comment!